Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy

Costa, 2010, Swelling properties of cross-linked DNA gels, Adv Colloid Interface Sci, 158, 21, 10.1016/j.cis.2009.10.002 Halliday, 2009, Polymer-based drug delivery devices for neurological disorders, CNS Neurol Disord Drug Targets, 8, 205, 10.2174/187152709788680698 Mundargi, 2008, Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, J Control Release, 125, 193, 10.1016/j.jconrel.2007.09.013 Simone, 2008, Polymeric carriers: role of geometry in drug delivery, Expert Opin Drug Deliv, 5, 1283, 10.1517/17425240802567846 Habraken, 2007, Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering, Adv Drug Deliv Rev, 59, 234, 10.1016/j.addr.2007.03.011 Prabaharan, 2008, Review paper: chitosan derivatives as promising materials for controlled drug delivery, J Biomater Appl, 23, 5, 10.1177/0885328208091562 Kojima, 2010, Design of stimuli-responsive dendrimers, Expert Opin Drug Deliv, 7, 307, 10.1517/17425240903530651 Ganta, 2008, A review of stimuli-responsive nanocarriers for drug and gene delivery, J Control Release, 126, 187, 10.1016/j.jconrel.2007.12.017 Kim, 1992, Hydrogels: swelling, drug loading, and release, Pharm Res, 9, 283, 10.1023/A:1015887213431 Amon, 1996, In vivo study of cell reactions on poly(methyl methacrylate) intraocular lenses with different surface properties, J Cataract Refract Surg, 22, 825, 10.1016/S0886-3350(96)80169-6 Stayton, 2005, ‘Smart’ delivery systems for biomolecular therapeutics, Orthod Craniofac Res, 8, 219, 10.1111/j.1601-6343.2005.00336.x Tabata, 1999, Biodegradation of hydrogel carrier incorporating fibroblast growth factor, Tissue Eng, 5, 127, 10.1089/ten.1999.5.127 Tabata, 2003, Tissue regeneration based on growth factor release, Tissue Eng, 9, S5, 10.1089/10763270360696941 Yamamoto, 2006, Tissue engineering by modulated gene delivery, Adv Drug Deliv Rev, 58, 535, 10.1016/j.addr.2006.03.003 Kushibiki, 2006, Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds, J Control Release, 112, 249, 10.1016/j.jconrel.2006.02.003 Matsumoto, 2006, Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma, Cancer Sci, 97, 313, 10.1111/j.1349-7006.2006.00174.x Kohara, 2010, Angiogenesis induced by controlled release of neuropeptide substance P, Biomaterials, 31, 8617, 10.1016/j.biomaterials.2010.07.079 Tanigo, 2010, Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration, J Control Release, 143, 201, 10.1016/j.jconrel.2009.12.027 Uesugi, 2010, An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy, J Control Release, 147, 269, 10.1016/j.jconrel.2010.07.127 Tabata, 2000, De novo formation of adipose tissue by controlled release of basic fibroblast growth factor, Tissue Eng, 6, 279, 10.1089/10763270050044452 Esaki, 2007, Controlled release systems of angiogenic growth factors for cardiovascular diseases, Expert Opin Drug Deliv, 4, 635, 10.1517/17425247.4.6.635 Kushibiki, 2004, A new gene delivery system based on controlled release technology, Curr Drug Deliv, 1, 153, 10.2174/1567201043479948 Nakajima, 2004, Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness, J Artif Organs, 7, 58, 10.1007/s10047-004-0252-1 Matsumoto, 1993, Heparin as an inducer of hepatocyte growth factor, J Biochem, 114, 820, 10.1093/oxfordjournals.jbchem.a124262 Abe, 2007, Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat, J Hepatol, 46, 286, 10.1016/j.jhep.2006.08.023 Pecly, 2006, Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration, Nephrol Dial Transplant, 21, 1212, 10.1093/ndt/gfk076 Turpie, 2001, A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement, N Engl J Med, 344, 619, 10.1056/NEJM200103013440901 Gray, 2008, Heparin and low-molecular-weight heparin, Thromb Haemost, 99, 807, 10.1160/TH08-01-0032 Sakiyama, 2007, Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides, J Biochem, 141, 653, 10.1093/jb/mvm067 Snyder, 1975, An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines, Anal Biochem, 64, 284, 10.1016/0003-2697(75)90431-5 de Jong, 1989, Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses, Clin Chem, 35, 1472, 10.1093/clinchem/35.7.1472 Yoshio, 2004, TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model, Kidney Int, 66, 1677, 10.1111/j.1523-1755.2004.00935.x Morgan, 1989, Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells, J Cell Sci, 94, 553, 10.1242/jcs.94.3.553 Kimura, 2010, Adipose tissue formation in collagen scaffolds with different biodegradabilities, J Biomater Sci Polym Ed, 21, 463, 10.1163/156856209X424396 Ogawa, 2010, In vitro proliferation and chondrogenic differentiation of rat bone marrow stem cells cultured with gelatin hydrogel microspheres for TGF-beta1 release, J Biomater Sci Polym Ed, 21, 609, 10.1163/156856209X434638 Kimura, 2010, Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue, Tissue Eng Part A, 16, 1263, 10.1089/ten.tea.2009.0322 Ohno, 2007, Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model, Ann Otol Rhinol Laryngol, 116, 762, 10.1177/000348940711601008 Panganiban, 2011, Hepatocyte growth factor in lung repair and pulmonary fibrosis, Acta Pharmacol Sin, 32, 12, 10.1038/aps.2010.90 Schievenbusch, 2009, Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts, Biochem Biophys Res Commun, 385, 55, 10.1016/j.bbrc.2009.05.010 Mizuno, 2008, HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease, Front Biosci, 13, 7072, 10.2741/3211 Jinnin, 2005, Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts, J Invest Dermatol, 124, 324, 10.1111/j.0022-202X.2004.23601.x Branton, 1999, TGF-beta and fibrosis, Microbes Infect, 1, 1349, 10.1016/S1286-4579(99)00250-6 Yang, 2003, Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction, Am J Pathol, 163, 621, 10.1016/S0002-9440(10)63689-9